Skip to main content

Table 3 Demographic and Clinic characteristics of patients between HPV negatives and patients with HPV16 and/or HPV18

From: Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men

Variable

HPV16/HPV18 N = 89*

HPV N = 45

p-value

Age

38 (32–44)

42 (35-49

0.029

Education years

12 (10–16)

12 (11–16)

0.803

Employed

57 (65)

27 (59)

0.780

CD4(cells/mL)

354 (244–506)

459 (287–699)

0.069

Viral Suppression

68 (76)

41 (91)

0.044

Time since diagnoses (years)

4.30 (1.63-8.55)

7.80 (4.29-12.0)

0.006

Time since treatment (years)

2.11 (0.21-5.44)

3.77 (0.96-7.39)

0.090

Regimen of ** HAART Initiation

   

  PI

36 (43)

11 (24)

0.136

  NNRTI

42 (50)

27 (61)

 

  Other

6 (7)

6 (13)

 
  1. Notes: Median and Interquartile range reported for continuous variable. Number of patients and percentage reported for categorical variables. Viral suppression defined as HIV-RNA <400 copies/mL.
  2. *89 patients distributed as: 65 patients with HPV16, 12 patients with HPV18 and 12 patients with HPV16 and HPV18.
  3. **Information available for 84 patients of HPV16/HPV18 and 45 or HPV-group.
  4. Regimens: PI Protease Inhibitor, NNRTI Non-Nucleoside Reverse Transcriptase Inhibitor, Other.